Drawing based on the description in the official product monograph. No photo yet.
“20 mg tablets: Elongated curved white to almost white tablet with "NVR" debossed on one side and "L20" debossed on the other side”
NVR L20 pill
Pill with imprint NVR L20 is white, capsule and has been identified as Ruxolitinib Phosphate 20 mg. It is used for polycythemia vera and primary myelofibrosis. It is supplied by Novartis Pharmaceuticals Canada Inc.
Sold in Canada
Ruxolitinib Phosphate 20 mg
- Brand
- Jakavi
- Imprint
- NVR L20
- Strength
- 20 mg
- Used for
- Polycythemia vera and primary myelofibrosis
- Color
- White
- Shape
- Capsule / oblong
- Form
- Tablet
- Manufacturer
- Novartis Pharmaceuticals Canada Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02388022
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Ruxolitinib used for?
Ruxolitinib is used for polycythemia vera and primary myelofibrosis.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Myelofibrosis
JAKAFI/JAKAFI XR is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF in adults.
Polycythemia Vera
JAKAFI/JAKAFI XR is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.
Acute Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older.
Chronic Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
From the FDA-approved label on DailyMed (published Aug 03, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows NVR L20. The parts can be split between the two sides, so turn the pill over and check both.
- It is white, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Jakavi by Novartis Pharmaceuticals Canada Inc.
In Canada: prescription only.
Ingredients
Active: Ruxolitinib (Ruxolitinib Phosphate)
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AC 79
Theophylline 450 mg
White, capsule, 19 mm
Used for asthma
-
AC 78
Theophylline 300 mg
White, capsule, 14 mm
Used for asthma
-
270 80
Atomoxetine 80 mg
Brown & white, capsule, 19 mm
Used for ADHD
-
266 18
Atomoxetine 18 mg
White & yellow, capsule, 19 mm
Used for ADHD
-
265 10
Atomoxetine 10 mg
White, capsule, 19 mm
Used for ADHD
-
ITR 100
Itraconazole 100 mg
White, capsule, 23 mm
Used for vaginal yeast infections and nail fungus
Other Ruxolitinib pills
- NVR L10 Ruxolitinib Phosphate 10 mg White, round Used for polycythemia vera and primary myelofibrosis
- INCY 10 Ruxolitinib 10.0 mg White, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- I 11 Ruxolitinib 11 mg Pink, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- NVR L15 Ruxolitinib Phosphate 15 mg White, oval Used for polycythemia vera and primary myelofibrosis
- INCY 15 Ruxolitinib 15.0 mg White, oval, 15 mm Used for polycythemia vera and primary myelofibrosis
- INCY 20 Ruxolitinib 20.0 mg White, capsule, 16 mm Used for polycythemia vera and primary myelofibrosis
- I 22 Ruxolitinib 22 mg Yellow, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- INCY 25 Ruxolitinib 25.0 mg White, oval, 18 mm Used for polycythemia vera and primary myelofibrosis